aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.51) by 25.49 percent. This is a 7.25 percent increase over losses of $(0.69) per share from the
aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.51) by 25.49 percent. This is a 7.25 percent increase over losses of $(0.69) per share from the same period last year.